Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of eighth biannual meeting (September 2015).

Malaria Journal
WHO Malaria Policy Advisory Committee and Secretariat

Abstract

The Malaria Policy Advisory Committee (MPAC) to the World Health Organization held its eighth meeting in Geneva, Switzerland from 16 to 18 September 2015. This article provides a summary of the discussions, conclusions and meeting recommendations. Meeting sessions included: recommendations from the Evidence Review Group (ERG) on mass drug administration; recommendations from the ERG on malaria in pregnancy; recommendations on when to scale back vector control; feedback on the Plasmodium vivax technical brief and the recommendation for G6PD testing before treatment; updates on artemisinin and artemisinin-based combination therapy resistance and the Greater Mekong Subregion elimination strategy; an update from the working group on malaria terminology; and updates on malaria elimination in the World Health Organization European region, the ERG on malaria elimination, and World Health Organization reform to support innovation, efficiency and quality in vector control tools. Policy statements, position statements, and guidelines that arise from the MPAC meeting conclusions and recommendations will be issued formally and disseminated to World Health Organization Member States by the World Health Organization Global Malaria Programme.

References

Dec 21, 2012·Malaria Journal·UNKNOWN WHO Malaria Policy Advisory Committee and Secretariat
Jun 22, 2013·Malaria Journal·UNKNOWN WHO Malaria Policy Advisory Committee and Secretariat
Dec 24, 2013·Malaria Journal·UNKNOWN WHO Malaria Policy Advisory Committee and Secretariat
Apr 17, 2015·Malaria Journal·UNKNOWN WHO Malaria Policy Advisory Committee and Secretariat
Aug 6, 2015·Malaria Journal·UNKNOWN WHO Malaria Policy Advisory Committee and Secretariat

❮ Previous
Next ❯

Citations

Aug 3, 2016·International Health·Phaik Yeong Cheah, Nicholas J White
Jul 9, 2016·The Journal of Infectious Diseases·Valérie BriandMichel Cot
Nov 21, 2016·The Lancet Infectious Diseases·Quique Bassat, Clara Menéndez
Dec 3, 2016·PLoS Neglected Tropical Diseases·Mu-Xin ChenWei Hu
Nov 30, 2016·The Lancet Global Health·Laura C SteinhardtMichelle A Chang
Jan 13, 2018·The Journal of Infectious Diseases·Manfred AccrombessiValérie Briand
Nov 30, 2018·The Cochrane Database of Systematic Reviews·Katherine GleaveHilary Ranson
Dec 19, 2017·Environmental Science and Pollution Research International·Mahmoud OsanlooAmir Amani
Oct 27, 2017·Current Medicinal Chemistry·Ana Cristina Lima LeiteGevanio Bezerra de Oliveira Filho
Apr 28, 2020·Transfusion·Jacquelyn FredrickJay E Menitove
Jul 4, 2020·The American Journal of Tropical Medicine and Hygiene·Rachel F DanielsSarah K Volkman
May 22, 2016·Evidence-based Medicine·Jenny Hill, Feiko O Ter Kuile
Jan 24, 2020·Malaria Journal·Tobias BrummaierRose McGready
Aug 6, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Sarah D'AlessandroNicoletta Basilico
Aug 1, 2020·Nature Communications·Patrick G T WalkerFeiko O Ter Kuile
Dec 1, 2017·PLoS Medicine·UNKNOWN malERA Refresh Consultative Panel on Combination Interventions and Modelling
Jan 25, 2021·Malaria Journal·Khalid A J Al Khaja, Reginald P Sequeira
Feb 6, 2018·The Lancet Infectious Diseases·Stephen J RogersonAnna M van Eijk
Feb 6, 2022·BMC Infectious Diseases·Hannah C SlaterGonzalo J Domingo

❮ Previous
Next ❯

Methods Mentioned

BETA
MDA

Software Mentioned

SP
IPTp
ISTp

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.